Quarterly report pursuant to Section 13 or 15(d)

CONDENSED BALANCE SHEETS

v3.7.0.1
CONDENSED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2017
Dec. 31, 2016
Current Assets:    
Cash $ 0 $ 197
Deferred financing costs 234 0
Total Assets 234 197
Current Liabilities:    
Accounts payable and accrued expenses 868 506
Accrued expenses - related party 1,568 1,348
Interest payable 5 57
Accrued interest - related party 404 346
Notes payable - related party 2,919 2,848
NSC notes payable, short-term 1,750 1,000
Derivative warrant liability 311 314
Total current liabilities 7,825 6,419
Convertible notes payable, at fair value 204 200
NSC notes payable, long-term (net of debt discount of $141 and $174, respectively) 1,109 1,826
Total Liabilities 9,138 8,445
Commitments and Contingencies (Note 7)
Stockholders' Deficit    
Common shares; 10,024,405 and 9,773,810 shares issued and outstanding as of March 31, 2017 and December 31, 2016, respectively 1 1
Common stock issuable, 0 and 250,595 shares as of March 31, 2017 and December 31, 2016, respectively 0 49
Additional paid-in capital 159 105
Accumulated deficit (9,064) (8,403)
Total Stockholders' Deficit (8,904) (8,248)
Total Liabilities and Stockholders' Deficit 234 197
Series A Preferred Stock [Member]    
Stockholders' Deficit    
Preferred Stock, Value, Issued $ 0 $ 0